Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.
Atherosclerosis
Atherosclerosis
Article
Statins and Insulin Resistance
Read time: 1h 1m 1s
About
Media
Watch time: 4m 57s
Articles
Statin-Fibrate Combination for the Treatment of Dyslipidaemia
Citation:
European Cardiology 2008;4(1):10–1
- Views:
2162
- Downloads:
0
Cardiovascular Disease Risk Prevention Across Europe
Citation:
European Cardiovascular Disease 2007;3(2):14–9
- Views:
331
- Downloads:
0
Ezetimibe - An Overview of its Low-density Lipoprotein Cholesterol Lowering Efficacy
Citation:
European Cardiovascular Disease 2007;3(1):23–5
- Views:
365
- Downloads:
0
Expanded Lipid Testing Critical to Managing Coronary Artery Disease
Citation:
European Cardiovascular Disease 2007;3(2):24–6
- Views:
135
- Downloads:
0